DIABETIC NEPHROPATHY: NOVELTY ABOUT THE DIABETIC NEPHROPATHY TREATMENT IN CHILDREN.

Autor:	Burlaka IA; BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE., Mityuryayeva IO; BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE., Shevchenko TA; BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE., Ilesanmi BM; BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE.
Jazyk:	angličtina
Zdroj:	Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 2023; Vol. 76 (4), pp. 857-866.
DOI:	10.36740/WLek202304124
Abstrakt:	Objective: The aim: To analyze and discuss the main aspects of the DN treatment in children. Patients and Methods: Materials and methods: Basic and modern data about the new aspects of the DN treatment analyzed in current review paper. Conclusions: DN is a major healthcare challenge and is a major cause of irreversible kidney damage. The DN course and progression leads to severe cardiovascular complications and early death. Treatment of DN is complicated clinical issue and requires individual and complex approach, including renoprotection, antihypertensive treatment. Nowadays, we are able to provide additional medications that can enhance the benefits of the renin-angiotensin-aldosterone (RAAS) blocking, Further search of neproprotective medicines for early DN correction in pediatric patients is still of high importance.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu